By Manufacturer Type

Generic / Authorized Generic Market Analysis

Cross-industry research covering Generic / Authorized Generic across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Generic / Authorized Generic

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Generic beta-lactams, glycopeptides, and azoles dominate HAI formularies by volume. The LOE waterfall for vancomycin, fluconazole, and meropenem has already run its course, meaning generic penetration in these classes is near-ceiling. Growth in this segment is predominantly volume-driven, tied to hospital capacity expansion in Asia Pacific and Latin America.

38%

Market Share

6.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments